More than 180 mushroom cultivators entered the Psychedelic Cup in Colorado on Thursday, and six were awarded top honors at Mile High Station in Denver. reMind sponsored the Psychedelic Club of Denver’s first annual event mushroom-cultivation competition as part of its mission to do advance the business of psychedelics ethically and responsibly. “It was an […]
Rebecca Nicholson is CEO and co-founder of 5D Ventures, a social impact and investing platform that focuses mainly on the psychedelic retreat industry. The firm’s portfolio includes Beckley Retreats in Jamaica/Netherlands, Holos in Costa Rica and Dimensions in Ontario (among others). Nicholson recently talked about growing up among psychonauts, her early days helping to set […]
Sam Mandel is the CEO of Ketamine Clinics Los Angeles, which he co-founded with his father in 2014. A lifelong advocate for mental health, he oversees the day-to-day operations of the clinic, including patient satisfaction, legal and compliance, marketing and publicity, construction and interior design, and business development. Mandel recently described the early days of […]
Stefany Nieto is the founder of Gwella / Mojo Microdose, a health and wellness company that offers mushroom-based products, content and tools. In 2020, she and her cofounders unveiled their Mojo line of gummies, which promise a microdose experience with a blend of functional mushrooms, herbs, and roots. The product is now available in more […]
Paul F. Austin is the founder and CEO of Third Wave, a psychedelics education and community platform that offers training courses, podcasts, and detailed information on psychedelic use. He is also the author of “Mastering Microdosing,” and currently serves as an advisor to Cybin Corp. Austin recently shared some of his earliest experiences with psychedelics, […]
A Massachusetts company that bills itself as “the first and only licensed provider of psychedelic health plans” announced on Tuesday that it will cover psilocybin-assisted therapy in states where it’s legal.
A state commission will soon vote to decide whether to commit ten percent of its funds, $42 million, toward a psychedelic-assisted therapy moonshot that could transform treatment for OUD nationally.
A federal appeals court directed the U.S. Drug Enforcement Administration to give a detailed explanation for keeping psilocybin, the hallucinogenic compound in psychedelic mushrooms, on the list of the most restricted substances.
Known as the Psychedelic Wellness and Healing Initiative of 2024, the measure is the third psychedelics-related prospective citizen-led measure attempting to qualify for next year’s ballot.
The City Council in Eureka, California, adopted a resolution this week to decriminalize psychedelic plants and fungi, making enforcement of laws against personal use, cultivation and possession a low priority for police. It’s at least the fifth local jurisdiction in the state to embrace the policy change.
A sad day in the psychedelics community today as news filters out that leading industry neuroscientist, Dr. Roland Griffiths, Ph.D., has passed.
The governor of California has vetoed a bill to legalize certain psychedelics and create a pathway to regulated access — a move that comes at a time when two states have already enacted comprehensive psychedelics policy reform and as two campaigns are working to put the issue on California’s 2024 ballot.
The City Council in Portland, Maine recently voted 6-3 in favor of a resolution deprioritizing local law enforcement for possession, use, cultivation for personal use or sharing psychedelic plants and fungi, placing controlled substances consumption as a public health matter.
There’s been some consistent movement of proposals concerning psychedelics across the United States.
The two-page legislation simply says that no federal funds can be used to “prevent any State or unit of local government from implementing such State’s or unit of local government’s own laws that authorize the use, distribution, sale, possession, research, or cultivation of psilocybin.”
The Multidisciplinary Association for Psychedelic Studies (MAPS) this week announced the successful completion of Phase 3 clinical trials for an MDMA treatment to help patients suffering from post-traumatic stress disorder, and said it brings the group a major step closer to filing a federal request to bring the treatment to market.
A powerful House committee has cleared two psychedelics amendments for floor consideration as part of a large-scale spending bill covering the Department of Defense (DOD).
Michigan lawmakers have passed a resolution urging the U.S. Congress, the Department of Defense (DoD) and the VA to prioritize research and funding on “non-technology treatment options” for veterans with psychological trauma from military service.
The bill would legalize the possession and cultivation of small amounts of certain entheogenic plants and fungi for adults 21 and older.
Leaders of the Colorado Natural Medicine Division, part of the state Department of Revenue, say the meetings are meant to engage stakeholders and keep the public informed.
Former Colorado Avalanche defenseman Kyle Quincey teamed up with Boulder biochemist Jeremy Widmann to build the 280 acres retreat center, the “Do Good Ranch,” on Colorado’s Western Slope in anticipation of the state’s legal psilocybin-assisted treatment market rollout in 2025.
Not only did Mayor Jacob Frey take unilateral action, but according to a representative from the Mayor’s office, he suffered no political backlash. Another sign of how the psychedelic landscape is changing.
Psychedelic Club of Denver says competition will collect meaningful data about different mushrooms
Two-thirds of participants with major depressive disorder or generalized anxiety disorder reported improvement.
So far, 20 out of 24 appointments to the body have been made, with key outstanding positions still vacant despite a statutory requirement saying they had to be filled by July 15.